Abstract: The present invention relates to a method for fractionating a starting material containing a protein and lipids or phospholipid. The method comprises providing the starting material containing the protein and the lipids or phospholipid, extruding the starting material into first solvent having a temperature of 20-200° C. to form a solid phase of a texturized matrix enriched with the protein and not soluble in the first solvent and a lipids-enriched or phospholipid-enriched fluid phase, and collecting, separately, the solid phase of the texturized matrix enriched with the protein and the lipids-enriched or phospholipid-enriched fluid phase.

Abstract: A method for extracting components includes the steps of heating an electronic device having one or more components to a predetermined temperature so as to substantially weaken a bonding substance arranged to bond the one or more components to the electronic device, and thereafter manipulating the electronic device to extract the one or more components from the electronic device.

Abstract: The invention is directed to droplet actuator devices and assay methods. The invention includes assay methods of conducting an assay comprising combining a sample with an umbelliferyl derivative, wherein the sample potentially comprises an enzyme capable of cleaving the umbelliferyl derivative and where the umbelliferyl derivative comprises an umbelliferyl core modified with one or more modifying moieties.

Abstract: A locking structure and a system using the same are provided. The locking structure includes a rotating unit, a first switch, a sheet and a second switch. The sheet includes a recess and contact to the first switch or the rotating unit. The second switch includes a protrusion movably disposed within the recess.

Abstract: The invention presents novel corn fermentation processes that remove the oil-rich fraction either during or after fermentation instead of before fermentation as usual. Besides recovery of high value oil-rich fraction of the corn, the processes also produce other value-added co-products such as that with high fiber or high protein but low oil contents.

Abstract: The present invention relates to compounds of Formula III, Formula 111(a), Formula V, Formula V(a), Formula A, Formula A 1, Formula A2, Formula A 3, or a pharmaceutically acceptable salt thereof that are useful as pharmaceutical agents, individually and/or in a combination with a chemotherapeutic agent: PLX-4032 (vemurafenib), or the catalytic mTOR inhibitor AZD8055, to treat a cancer and/or a cancer metastasis, for example a cancer harboring a BRAF protein kinase mutation and/or a HRAS protein mutation. Also, a method of treating and/or preventing malaria in a subject, the method comprising administering a therapeutically effective amount of a compound of Formula A, Formula A 1, Formula A2, Formula A 3, or a pharmaceutically acceptable salt thereof to the subject in need.

Abstract: Disclosed are benzamide derivatives useful in slowing the expansion of cancer cells.

Abstract: The disclosure discloses a Generic Mapping Procedure (GMP) mapping method for an Optical channel Data Unit (ODU), including: caching low-level ODUk data to a memory according to the rate of low-level ODUk data stream; generating an adjustment byte in a mapping process and encoding the adjustment byte; generating read enable of the cached data by an algorithm according to the adjustment byte, reading the cached low-level ODUk data, and generating Optical channel Data Tributary Unit (ODTU) data according to the read data; and crossing a time slot of the ODTU data in multiple channels to that of a high-level ODU payload, and forming the data in the time slot of the high-level ODU payload and the encoded adjustment byte into a completed high-level ODU frame. The disclosure may further provide a GMP mapping apparatus for an ODU. According to a technical solution of the disclosure, the GMP mapping of the ODU can be implemented according to the dynamic change of a service rate.

Abstract: Disclosed are benzamide derivatives having the formula wherein X is selected from the group consisting of H, halo, —C1-C6 alkyl, aryl, —C3-C7 cycloalkyl, and -3- to 10-membered heterocycle, wherein the —C1-C6 alkyl, aryl, —C3-C7 cycloalkyl, and -3- to 10-membered heterocycle may be unsubstituted or substituted; Y is selected from the group consisting of H, —C1-C6 alkyl, and —C3-C7 cycloalkyl, the —C1-C6 alkyl, aryl, —C3-C7 cycloalkyl, and -3- to 10-membered heterocycle may be unsubstituted or substituted; Z is selected from the group consisting of —NHOH and phenylene diamine group (II) of structure and wherein Q is selected from the group consisting of H, F and Cl. These benzamide derivatives are useful in slowing the expansion of cancer cells.

Abstract: The invention provides compounds that inhibit ROCK activity. In certain embodiments the compounds of the invention enhance cognitive function. The invention is also directed to pharmaceutical compositions that comprise ROCK inhibitors and to methods enhance cognitive function and reducing and/or treat cognitive function decline.

Abstract: The present invention provides forms of curcumin and the pharmaceutical compositions thereof. The forms of curcumin disclosed herein are curcumin polymorph Form III, curcumin-2-aminobenzimidazole co-crystal, and curcumin-L-lysine co-crystal. Further, the invention provides methods inhibiting cancer cells and HSV-1 using these curcumin novel solid forms.

Abstract: Disclosed are a light-emitting member and a method for preparing the same as well as a display device. The light-emitting member includes a first electrode layer, a second electrode layer having a polarity opposite to that of the first electrode layer, a light-emitting layer and an isolation layer, the light-emitting layer is located on the first electrode layer, the second electrode layer is located on a side of the light-emitting layer, and the isolation layer is located on a side of the first electrode layer to isolate the first electrode layer from the second electrode layer.

Abstract: The present application relates to a high temperature carbon dioxide corrosion inhibitor comprising the following components by mass percent: amide compound 15˜50%, organic alkynol 10˜25%, mercaptan acid 5˜15%, piperidine 5˜25%, mercaptopyridine 5˜15%, and solvent 25˜60%. The corrosion inhibitor has excellent corrosion inhibition for CO2 corrosion of oil field water system at a high temperature (150˜250° C.).

Abstract: An electrical module and a device using the same are provided. The electrical module comprises a base, a composite component and a pressing sheet. The composite component is disposed on the base and comprises a pad and a conductive sheet. The conductive sheet is embedded in the pad, and the pressing sheet presses on the pad. The pad comprises a main body and a protrusion. The main body has a surface. The protrusion is disposed on the surface of the main body and is compressed between the surface of the main body and the base.

Abstract: The invention encompasses a compound derived from hydroxamic acid that may be used to slow the expansion of cancer cells and thus is effective in the treatment of cancer. Generally, the disclosed compound includes a benzimidazole group coupled to a hydroxyamide of five or more unsubstituted carbon atoms and any pharmaceutically acceptable salts, solvates and chemically protected forms thereof. Also disclosed are pharmacological compositions including the compound and methods of using the compound to slow the expansion of cancer cells as well as methods of using the compound to treat cancer.

Abstract: The present invention relates to compounds of formulas III and V that are useful as pharmaceutical agents, particularly as autophagy inhibitors.

Abstract: A bias circuit according to an embodiment is a bias circuit that supplies a bias voltage to an amplifying element. The bias circuit of the embodiment includes a first current source that has a characteristic of varying an output current with the surrounding temperature variations, and a second current source that has a different output characteristic from the first current source and that can control the output current. The bias circuit of the embodiment also includes a comparator for comparing the output current of the first current source with the output current of the second current source, and a bias supply part that controls the output current of the second current source on the basis of the comparison result of the comparator and supplies a bias voltage to the amplifying element in accordance with the comparison result.

Abstract: The present invention comprises compounds of Formula I and their use in the inhibition of cell proliferation in therapeutic treatments. Pharmaceutical compositions comprising at least one compound of Formula I and at least one pharmaceutical excipient are disclosed, as well as methods of using compounds of Formula I and pharmaceutical compositions thereof for treatment of hyper-proliferative diseases and other disorders.

Abstract: Disclosed are benzamide derivatives useful in slowing the expansion of cancer cells including the killing of cancer cells and in the treatment of cancer.

Abstract: The present invention relates to methods for making a fatty acid N-acylalkanolamine having the formula: One of the methods comprises the steps of providing a vinyl ester of a fatty acid having the formula: providing a primary or secondary alkanolamine having the formula: NHR1R2; and reacting the vinyl ester of the fatty acid with the alkanolamine under conditions effective to form the fatty acid N-acylalkanolamine. The other method comprises the steps of providing a fatty acid; purifying the fatty acid; providing a primary or secondary alkanolamine having the formula: NHR1R2; reacting the fatty acid with the alkanolamine under conditions effective to form the fatty acid N-acylalkanolamine; and purifying the formed fatty acid N-acylalkanolamine.